VitaNova Life Sciences (VNOV) Total Liabilities (2017 - 2026)
VitaNova Life Sciences' (VNOV) quarterly Total Liabilities came in at $395781.0 in Q2 2026, up 13.87% YoY from $347567.0 in Q2 2025, and down 13.58% on a QoQ basis from $457975.0 in Q1 2026.
VitaNova Life Sciences (VNOV) Total Liabilities (2017 - 2026) Analysis & Trends
VitaNova Life Sciences (VNOV) has 10 years of Total Liabilities data on file, last reported at $395781.0 in Q2 2026.
- Quarterly Total Liabilities rose 13.87% year-over-year to $395781.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $395781.0 (up 13.87% YoY) and the FY2026 annual result came in at $395781.0, up 13.87% from the prior year.
- Total Liabilities declined to $395781.0 in Q2 2026, from $457975.0 in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $457975.0 in Q1 2026 to a low of $11013.0 in Q1 2023.
- A 5-year average of $185949.4 and a median of $115247.0 in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2023 — Total Liabilities slumped 78.19% — and 2024, when it soared 749.67%.
- Tracing VNOV's Total Liabilities over 5 years: stood at $35190.0 in 2022, then jumped by 162.05% to $92217.0 in 2023, then surged by 142.84% to $223938.0 in 2024, then jumped by 95.61% to $438051.0 in 2025, then slipped by 9.65% to $395781.0 in 2026.
- The last three Total Liabilities figures came in at $395781.0 (Q2 2026), $457975.0 (Q1 2026), and $438051.0 (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 88.33 Bn |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 1.05 Bn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 1.00 Bn |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 6.66 Bn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | 8.71 Mn |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | 77.77 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | 2.66 Bn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | 253.22 Mn |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | 40.79 Mn |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 395,781.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 395,781.00 |
| Jan 31, 2026 | 457,975.00 |
| Oct 31, 2025 | 438,051.00 |
| Jul 31, 2025 | 379,975.00 |
| Apr 30, 2025 | 347,567.00 |
| Jan 31, 2025 | 212,789.00 |
| Oct 31, 2024 | 223,938.00 |
| Jul 31, 2024 | 199,374.00 |
| Apr 30, 2024 | 136,920.00 |
| Jan 31, 2024 | 93,574.00 |
| Oct 31, 2023 | 92,217.00 |
| Jul 31, 2023 | 83,462.00 |
| Apr 30, 2023 | 67,943.00 |
| Jan 31, 2023 | 11,013.00 |
| Oct 31, 2022 | 35,190.00 |
| Jul 31, 2022 | 62,738.00 |
| Apr 30, 2022 | 58,091.00 |
| Jan 31, 2022 | 50,491.00 |
| Oct 31, 2021 | 48,791.00 |
| Jul 31, 2021 | 32,107.00 |